Neurotoxicity Syndromes - Psychology
Research News and Information

Sunday, November 22, 2009

Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats.

29 Jun 2009 This investigation was undertaken to study the effect of pentoxifylline (PTX) on iminodipropionitrile (IDPN)-induced behavioral abnormalities [excitation with choreiform and circling movements (ECC) syndrome] in rats. The animals were ... Read more...

Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study.

27 Apr 2009 The aim of this study was to determine and compare the anticonvulsant and acute adverse (neurotoxic) effects of imperatorin and osthole (two natural coumarin derivatives) with valproate (a classical antiepileptic drug) in the maximal electroshock ... Read more...

Selective aspiration or neurotoxic lesions of orbital frontal areas 11 and 13 spared monkeys' performance on the object discrimination reversal task.

2 Mar 2009 Damage to the orbital frontal cortex (OFC) has long been associated with reversal learning deficits in several species. In monkeys, this impairment follows lesions that include several OFC subfields. However, the different connectional patterns of ... Read more...

Latest indexed articles for 'Neurotoxicity Syndromes - Psychology'

These are the very latest articles for this heading:

• Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats. 29 Jun 2009
• Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study. 27 Apr 2009
• Selective aspiration or neurotoxic lesions of orbital frontal areas 11 and 13 spared monkeys' performance on the object discrimination reversal task. 2 Mar 2009
• Synthesis of some new coumarin incorporated thiazolyl semicarbazones as anticonvulsants. 27 Feb 2009
• New derivatives of benzylamide with anticonvulsant activity. 27 Feb 2009
• Synthesis and anticonvulsant activity of some novel fused heterocyclic 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. 27 Feb 2009
• Survivors from beta-fluoroethyl acetate poisoning show a selective cerebellar syndrome. 7 Feb 2009
• Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring? 30 Jan 2009
• N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study. 11 Nov 2008
• A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. 7 Sep 2008
• Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant. 30 Aug 2008
• Developmental neurotoxicity of parathion: progressive effects on serotonergic systems in adolescence and adulthood. 18 Aug 2008
• Insulin-like growth factor-I mitigates motor coordination deficits associated with neonatal alcohol exposure in rats. 6 Aug 2008
• Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice. 25 Jul 2008
• Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures. 15 Jul 2008
• Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. 27 May 2008
• Neurobehavioral testing in human risk assessment. 16 Apr 2008
• Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies. 9 Apr 2008
• Responsiveness of cerebral and hepatic cytochrome P450s in rat offspring prenatally exposed to lindane. 6 Apr 2008
• The inhalation toxicity of di- and triethanolamine upon repeated exposure. 2 Mar 2008

See a longer list of these articles.

Technical information about 'Neurotoxicity Syndromes'

Definition: Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.

Descriptor UI: D020258

Alternative terms: Neurotoxicity Syndromes; Neurotoxicity Syndrome; Syndrome, Neurotoxicity; Syndromes, Neurotoxicity; Neurotoxin Disorders; Neurotoxin Disorder; Neurotoxic Disorders; Neurotoxic Disorder; Neurotoxin Diseases; Neurotoxin Disease; Poisoning, Nervous System; Nervous System Poisonings; Poisonings, Nervous System; Nervous System Poisoning; Encephalopathy, Toxic; Encephalopathies, Toxic; Toxic Encephalopathies; Toxic Encephalopathy; Toxic Encephalitis; Encephalitides, Toxic; Encephalitis, Toxic; Toxic Encephalitides;

Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.720; C21.613.705;

History Note: 2000